Should we implement ‘opt-out' HIV testing for patients with lymphoma?
Open Access
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Clinical Medicine
- Vol. 9 (4) , 320-322
- https://doi.org/10.7861/clinmedicine.9-4-320
Abstract
Patients with HIV are dying due to late diagnosis and physicians are being encouraged to increase HIV testing. The uptake of opt-in HIV screening for 113 lymphoma patients was audited at University College London Hospital. Of the 113 patients, 46 were not tested (41%). Previous research in the antenatal setting suggests that adopting opt-out screening would increase testing rates.Keywords
This publication has 7 references indexed in Scilit:
- Reducing the length of time between HIV infection and diagnosisBMJ, 2007
- HIV infection and lymphomaJournal of Clinical Pathology, 2006
- Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Blood, 2005
- Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*Annals of Internal Medicine, 2002
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin’s lymphomaAnnals of Oncology, 2001
- Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisoneBritish Journal of Haematology, 2001
- Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the testBMJ, 1998